🔊 Market Review and Preview

Here’s everything you might have missed last week on Wall Street, and everything to watch in the week ahead.

Jan 16, 2026

Apr 11, 2026

•

2 min read

Plus, a precision oncology biotech with room to run, a CNS drug challenger with nearly $4B in projected peak sales, and more...

Apr 4, 2026

•

2 min read

Plus, a top-1% analyst's highest-conviction AI infrastructure bet and the post-IPO software name Goldman says the market is missing out on.

Apr 1, 2026

•

2 min read

The market may be missing a protein upgrade that favors eggs.